Drugmakers feel empowered to resist foreign price controls — confident that the Trump administration will have their backs.

NOV 7 - US President Donald Trump has announced deals that aim to lower the cost of popular weight-loss drugs, as pharmaceutical prices take centre stage Kenya breaking news | Kenya news today | ...

(Reuters) -Several pharmaceutical companies have said they will sell drugs direct to patients in the U.S. and offered ...

The drugs are part of a new generation of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

The Trump administration on Thursday announced a much-anticipated deal with drugmakers Eli Lilly and Novo Nordisk that aims to deliver lower prices for their popular GLP-1 drugs to certain Medicare ...

Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.

Presented by the Coalition to Strengthen America’s Healthcare — State Medicaid programs that choose to participate in the model will be able to purchase drugs included in the pilot at prices ...

CMS introduced the GENEROUS Model to reduce Medicaid drug costs, enhance access, and improve health outcomes for ...

US President Donald Trump announced deals Thursday with pharmaceutical giants Eli Lilly and Novo Nordisk to lower the prices ...

Access to the drugs has been a consistent problem for patients because of their cost — around $500 a month for higher doses — ...